Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 External defibrillator industry 3600 synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 End-use trends
Chapter 3 External Defibrillator Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cardiac diseases
3.2.1.2 Technological advancements and introduction of innovative devices
3.2.1.3 Increasing public awareness
3.2.1.4 Surging demand for wearable cardioverter defibrillators
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of the devices
3.2.2.2 Product recalls
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Pricing analysis, 2022
3.8 Product pipeline analysis
3.9 Technology landscape
3.10 Startup scenario
3.11 Gap analysis
3.12 Porter’s analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022
Chapter 5 External Defibrillator Market Size and Forecast, By Product (USD Million & Units)
5.1 Key product trends
5.2 Manual External Defibrillator
5.3 Automated External Defibrillator
5.3.1 Semi-automated external defibrillator
5.3.2 Fully automated external defibrillator
5.4 Wearable External Cardioverter Defibrillator
Chapter 6 External Ddefibrillator Market Size and Forecast, By End-use (USD Million)
6.1 Key end-use trends
6.2 Hospitals
6.3 Prehospital Care
6.4 Ambulatory Surgical Centers
6.5 Others
Chapter 7 External defibrillator Market Size and Forecast, By Region (USD Million & Units)
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.2 Boston Scientific Corporation
8.3 Koninklijke Philips
8.4 Stryker Corporation
8.5 Medtronic plc
8.6 LivaNova PLC
8.7 Asahi Kasei Corporation (ZOLL Medical Corporation)
8.8 Nihon Kohden Corporation
8.9 MicroPort Scientific Corporation
8.10 Element Science Inc.
8.11 AMI Italia
8.12 Bexen Cardio
8.13 BPL Medical Technologies
8.14 Corpuls
8.15 Schiller AG
